The PATHway Study: Primary Care Based Depression Prevention in Adolescents

NCT05203198 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2026-01-08

No results posted yet for this study

Summary

Prevention of depressive disorders has become a key priority for the NIMH, but the investigators have no widely available public health strategy to reduce morbidity and mortality. To address this need, the investigators developed and evaluated the primary care based-technology "behavioral vaccine," Competent Adulthood Transition with Cognitive-Behavioral Humanistic and Interpersonal Therapy (CATCH-IT). The investigators will engage N=4 health systems representative of the United States health care system, and conduct a factorial design study to optimize the intervention in preparation for an implementation study and eventual dissemination.

Conditions

Interventions

BEHAVIORAL

Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training

Self-directed, technology-based, depression prevention program for adolescents and parents.

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    collaborator OTHER
  • Endeavor Health

    collaborator OTHER
  • University of Chicago

    collaborator OTHER
  • National Institute of Mental Health (NIMH)

    collaborator NIH
  • Mile Square Health Center

    collaborator OTHER
  • Lawndale Christian Health Center

    collaborator OTHER
  • Ann & Robert H Lurie Children's Hospital of Chicago

    collaborator OTHER
  • University of Illinois at Chicago

    lead OTHER

Principal Investigators

  • Benjamin W Van Voorhees, MD, MPH · UIC, College of Medicine

  • Tracy RG Gladstone, PhD · Wellesley College

  • Calvin Rusiewski, MBBS · UIC, College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
13 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2024-10-31
Completion
2026-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05203198 on ClinicalTrials.gov